Velarion · Company Intelligence
CompBrief
Fiscal year 2025

George Magrath — FY2025 total compensation $1,493,383

George Magrath is Chief Executive Officer of Opus Genetics, Inc. (IRD). The company reported total compensation of $1,493,383 for fiscal year 2025.

01

Fiscal year 2025 compensation

Salary$598,000
Bonus$0
Stock awards$307,548
Option awards$212,045
Non-equity incentive plan$361,790
Pension and non-qualified deferred compensation$0
All other compensation$14,000
Total$1,493,383

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.

Cited to the compensation disclosure Opus Genetics, Inc. filed March 23, 2026, accession 0001140361-26-010757.

02

History — every fiscal year held

Fiscal yearRoleSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
FY2025Chief Executive Officer$598,000$0$307,548$212,045$361,790$0$14,000$1,493,383
FY2024Chief Executive Officer$575,000$0$0$0$300,438$0$13,800$889,238

Totals as disclosed in each year's own compensation disclosure for Opus Genetics, Inc..

03

Peer context

Peer-group chief executive median$3,579,202
Difference from that median$-2,085,819
Percentile within the disclosed peer group1st
Peers with a disclosed figure5

Medians and percentiles are computed across the peer group Opus Genetics, Inc. discloses in its own compensation disclosure.

04

The other named executive officers of Opus Genetics, Inc.

Named executive officerRoleFY2025 total
George Magrath this pageChief Executive Officer$1,493,383
Ashwath JayagopalChief Scientific and Development Officer$764,848
Joseph SchachleChief Operating Officer$718,408

The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Opus Genetics, Inc. compensation brief.

05

The company page

George Magrath's compensation sits inside Opus Genetics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.

The Opus Genetics, Inc. (IRD) compensation brief